First reported case of secondary mixed phenotype acute leukemia after multiple myeloma

In recent years the outcome of patients with multiple myeloma (MM) has significantly improved, due to new drugs. However, some agents, i.e. the alkylating drug melphalan, can be associated with an increased incidence of secondary malignancies. Myelodysplastic syndromes and acute myeloid leukemia are...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Am J Blood Res
Glavni autori: Bacchiarri, Francesca, Sammartano, Vincenzo, Santoni, Adele, Raspadori, Donatella, Zappone, Elisabetta, Defina, Marzia, Ciofini, Sara, Sicuranza, Anna, Bocchia, Monica, Gozzetti, Alessandro
Format: Artigo
Jezik:Inglês
Izdano: e-Century Publishing Corporation 2021
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8010609/
https://ncbi.nlm.nih.gov/pubmed/33796400
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items